Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2186-2194

  Lassus, Johan ^a,b   Gayat, Etienne ^b,c   Mueller, Christian ^d   Peacock, W Frank ^e   Spinar, Jindrich ^f,g   Harjola, Veli Pekka ^a   Van Kimmenade, Roland ^h   Pathak, Atul ⁱ   Mueller, Thomas ^j   Disomma, Salvatore ^k   Metra, Marco ^l   Pascual Figal, Domingo ^m,n   Laribi, Said ^b   Logeart, Damien ^b   Nouira, Semir ^o   Sato, Naoki ^p   Potocki, Michael ^d   Parenica, Jiri ^f,g   Collet, Corinne ^b   Cohen Solal, Alain ^b   Januzzi Jr , James L ^q   Mebazaa, Alexandre ^b   more..

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HÔPITAL LARIBOISIÈRE   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^g MASARYK UNIVERSITY   (Czech Republic)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ TOULOUSE UNIVERSITY HOSPITAL   (France)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l UNIVERSITY OF BRESCIA   (Italy)

^m HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

ⁿ UNIVERSITY OF MURCIA   (Spain)

^o FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^p NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^q MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

ADHF; Biomarkers; Mortality; Reclassification; Risk prediction

Indexed keywords

ACETYLSALICYLIC ACID; ADRENOMEDULLIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SODIUM; TROPONIN I; TROPONIN T;

ACUTE HEART FAILURE; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTERNATIONAL COOPERATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; ACUTE DISEASE; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; FOLLOW UP; HEALTH; MULTICENTER STUDY; PREDICTIVE VALUE; RISK FACTOR; TRENDS; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GLOBAL HEALTH; HEART FAILURE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84885623462     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.228     Document Type: Article

References (30)

1. W.T. Abraham, G.C. Fonarow, and N.M. Albert Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) J Am Coll Cardiol 52 2008 347 356
2. G.C. Fonarow, K.F. Adams Jr., W.T. Abraham, C.W. Yancy, W.J. Boscardin ADHERE Scientific Advisory Committee, Study Group, and Investigators Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
3. V.P. Harjola, F. Follath, and M.S. Nieminen Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure Eur J Heart Fail 12 2010 239 248
4. D.S. Lee, P.C. Austin, J.L. Rouleau, P.P. Liu, D. Naimark, and J.V. Tu Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
5. C.M. O'Connor, V. Hasselblad, and R.H. Mehta Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score J Am Coll Cardiol 55 2010 872 878
6. K. Siirila-Waris, J. Lassus, J. Melin, K. Peuhkurinen, M.S. Nieminen, and V.P. Harjola Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure Eur Heart J 27 2006 3011 3017
7. E. Braunwald Biomarkers in heart failure N Engl J Med 358 2008 2148 2159
8. M. Yanavitski, and M.M. Givertz Novel biomarkers in acute heart failure Curr Heart Fail Rep 8 2011 206 211
9. A. Maisel, C. Mueller, and K. Adams Jr. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
10. J.L. Januzzi, R. van Kimmenade, and J. Lainchbury NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
11. G.C. Fonarow, W.F. Peacock, and T.B. Horwich Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE Am J Cardiol 101 2008 231 237
12. J. Lassus, V.P. Harjola, and R. Sund Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Eur Heart J 28 2007 1841 1847
13. M.A. Hlatky, P. Greenland, and D.K. Arnett Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416
14. D.A. Morrow, and J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952
15. R.R. van Kimmenade, and J.L. Januzzi Jr. Emerging biomarkers in heart failure Clin Chem 58 2012 127 138
16. B. Dieplinger, A. Gegenhuber, M. Haltmayer, and T. Mueller Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath Heart 95 2009 1508 1513
17. N. Sato, K. Kajimoto, and K. Asai Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data Am Heart J 159 2010 949-955.e1
18. M. Metra, S. Nodari, and G. Parrinello Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance Eur J Heart Fail 10 2008 188 195
19. C. Mueller, A. Scholer, and K. Laule-Kilian Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 2004 647 654
20. T. Reichlin, T. Socrates, and P. Egli Use of myeloperoxidase for risk stratification in acute heart failure Clin Chem 56 2010 944 951
21. D.A. Pascual-Figal, S. Manzano-Fernandez, and M. Boronat Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure Eur J Heart Fail 13 2011 718 725
22. J. Spinar, J. Parenica, and J. Vitovec Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry Crit Care 15 2011 R291
23. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, K. Dickstein, and A. Cohen-Solal ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
24. M.S. Nieminen, M. Bohm, and M.R. Cowie Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 384 416
25. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2003 2154 2169
26. M.J. Pencina, R.B.S. D'Agostino, R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 [discussion 207-12]
27. N.R. Cook Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve Clin Chem 54 2008 17 23
28. C. Mueller, K. Laule-Kilian, A. Christ, H.P. Brunner-La Rocca, and A.P. Perruchoud Inflammation and long-term mortality in acute congestive heart failure Am Heart J 151 2006 845 850
29. W.H. Tang, K. Shrestha, and F. Van Lente Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure Am J Cardiol 101 2008 370 373
30. R.V. Shah, and J.L. Januzzi Jr. ST2: a novel remodeling biomarker in acute and chronic heart failure Curr Heart Fail Rep 7 2010 9 14